Several factors may be responsible for the high prevalence of premature atherosclerosis in diabetes mellitus [1] , including possible alterations in the reverse cholesterol transport system [2] [3] [4] [5] [6] [7] .
Summary Alterations in the reverse cholesterol transport system have been described in diabetic mellitus patients in several but not all studies. Furthermore, recently published investigations suggest that a faster "in vitro" transfer rate of cholesteryl ester from high density lipoproteins to apoB-containing lipoproteins could be solely ascribed to variation of the plasma lipoprotein composition and concentration in the diabetic state. The present study analysed the influence of lipoprotein glycation on the cholesteryl ester transfer protein-mediated transfer of esterified cholesterol from high density lipoprotein and its subfractions to lighter density lipoproteins. For this purpose two sets of "in vitro" experiments were carried out utilizing:1) plasma lipoproteins drawn from diabetic and from normal subjects and; 2) normal lipoproteins or partially purified cholesteryl ester transfer protein submitted to "in vitro" glycation. The transfer rate of 14 C-cholesteryl ester labelled HDL subfractions to low or very low density lipoproteins was measured in all experiments. After incubations with plasma d > 1.21 g/ml or with purified cholesteryl ester transfer protein, apoB-containing lipoproteins were precipitated with a dextran sulfate/MgCl 2 solution. The "in vitro" glycation of the partially purified cholesteryl ester transfer protein markedly impaired its activity. However, greater transfer rates were observed when lipoproteins from diabetic individuals or the "in vitro" glycated lipoproteins were utilized. This effect was attributed to glycation of the protein component of HDL. In conclusion, lipoprotein glycation elicits an enrichment of the apoB-containing lipoproteins with cholesteryl ester that is likely related to the premature atherosclerosis in patients with poorly controlled diabetes. [Diabetologia (1997) 40: 1085-1093] Keywords Cholesteryl ester transfer, CETP, lipoprotein glycation, diabetes mellitus, atherogenesis.
The role of CETP in atherogenesis is controversial [2, 10, 11, 16] . High levels of plasma CETP were reported in several dyslipidaemias that are clearly related to the development of premature atherosclerosis [17] [18] [19] [20] [21] . Further confusion on this issue arises from a recent population study suggesting that elevated plasma CETP levels protect against atherosclerosis [22] , whereas elevated CETP concentrations in transgenic mice may facilitate the development of premature atherosclerosis [16] .
Conflicting results have been obtained in several studies measuring CETP activity in diabetes: increased, diminished and no alterated cholesteryl ester transfer between lipoproteins has been reported in insulin-dependent and non-insulin-dependent diabetes (IDDM and NIDDM) [3] [4] [5] [6] [7] [23] [24] [25] . These discrepancies are likely to be related to the different methods used to measure the cholesteryl ester transfer between LP, and may also be ascribed to variable concentrations and compositions of the acceptor and donor LP utilized in the "in vitro" tests. For instance, the plasma concentration of CETP is consistently within the normal range in diabetes [4, 24] , thus the faster transfer rate of cholesteryl ester from HDL to lighter density LP could be attributed to the higher levels of cholesteryl ester acceptor LPs in diabetic plasma in the majority of the studies reported so far [3] [4] [5] [6] [7] 24] . Surprisingly, in all these investigations the role played by glycation of the plasma LPs has not been taken into account. Glycation is responsible for several metabolic disturbances: diminished binding and internalization of LP by fibroblasts [26] [27] [28] , decreased LP lipase hydrolysis [29] and heparin-dependent binding capacity of TG-rich lipoproteins [30] , enhanced rate of HDL [31] and diminished rate of LDL and VLDL catabolism in blood [29, 32] , and reduced lecithin-cholesterol acyl transferase (LCAT) activity [33] . Furthermore, cholesteryl ester synthesis in macrophages is enhanced after internalization of glycated lipoproteins via specific receptors [34] , and the HDL-receptor mediated cell cholesterol efflux is diminished by glycation of HDL [35] .
The present investigation assesses whether glycation of the whole plasma LPs as well as of the LP components influences the process of cholesteryl ester transfer from HDL to apoB-containing LP, namely, the reverse cholesterol transport system.
Subjects, materials and methods
Isolation of LP and radiolabelling of HDL. Fasting blood from normal control (total cholesterol = 4.60 ± 0.64 mmol/l; triglycerides = 1.43 ± 0.58 mmol/l; plasma glucose ≤ 5.5 mmol/l; HbA 1 c ≤ 80 g/l, n = 11) and from poorly controlled diabetic subjects (total cholesterol = 5.00 ± 0.80 mmol/l; triglycerides = 1.52 ± 0.36 mmol/l; plasma glucose ≥ 16.6 mmol/l; HbA 1 c ≥ 140 g/l, n = 6) was drawn over 2 mmol/l EDTA (10 m l/ml) and the following preservatives were added to the plasma pools: 2 mmol/l benzamidine (5 m l/ml), 0.5 % gentamicin plus 15 mmol/l chloramphenicol (20 m l/ml), 0.5 mmol/l phenyl-methyl-sulfonyl-fluoride in DMSO (0.5 m l/ml), and aprotinin (10 m l/ml). Plasma lipoproteins were separated by sequential ultracentrifugation [36] ; VLDL was obtained at d = 1.006 g/mL for 12 h, 100 000 g at 4°C in an L-8 ultracentrifuge (Beckman Instruments, Palo Alto, Calif., USA); LDL was obtained at d = 1.006-1.063 g/ml for 20 h. The LP were dialysed against phosphate buffered saline (PBS) (150 mmol/l NaCl, 20 mmol/ l Na 2 HPO 4 , 14 mmol/l NaH 2 PO 4 , 1 mmol/l NaOH and 0.2 mmol/l EDTA) and maintained at 4°C after sterilization.
The d > 1.063 g/ml fraction was labelled with 4-14 C-cholesterol (New England Nuclear, Boston, Mass., USA) at 4°C for 48 h according to the method of Dobiasova et al. [37] or with (cholesteryl-4-14 C) oleate at 37°C for 24 h. Isotope purity was previously checked by preparative thin-layer chromatography (TLC) [38] and shown to be greater than 95 %. In order to esterify 4-14 C-cholesterol-HDL by the endogenous LCAT enzyme, the same d > 1.063 g/ml sample was incubated at 37°C for 48 h and HDL 2 and HDL 3 fractions were then separated by ultracentrifugation at density ranges 1.063-1.125 and 1.125-1.210 g/ml, respectively. HDL fractions were also dialysed against the phosphate buffer. Unesterified and esterified cholesterol were separated by thin layer chromatography (TLC) on silica gel G in a development system of hexane:ethyl ether:acetic acid Total cholesterol (Chod-Pap, Merck S/A, Sã o Paulo, Brazil), unesterified cholesterol (Boehringer Mannheim Biochemicals, Mannheim, Germany) and triglycerides (Enz-Color, Biadiagnostica, Pinhais PR, Brazil) were determined by enzymatic techniques. Protein was determined by the method of Lowry et al. [39] . Glycated haemoglobin (HbA 1 c ) was measured by the affinity column system Glyc-Affin Ghb (Isolab Inc., Akron, Ohio, USA). Phospholipids were analysed by the Bartlett procedure [40] . Apo A-I-lipoprotein was estimated by radioimmunoassay (Pharmacia Diagnostics AB, Uppsala, Sweden).
Purification of Human CETP. CETP was partially purified from human plasma by the method described by Morton and Zilversmit [41] , using phenyl-Sepharose and CM-cellulose chromatography. This protein was purified 800 times relative to the LP-deficient plasma and was deficient in LCAT activity.
LP and CETP glycation. LPs were glycated by the procedure of Witztum et al. [26] . Briefly, 0.5 ml of sterile 200 mmol/l glucose solution (Sigma Chemical Company, St. Louis, Mo., USA) in PBS with EDTA and preservatives, pH = 7.35, and 200 mmol/l of freshly prepared sodium cyanoborohydride (NaCNBH 3 ) (Sigma) were added to 3 mg of LP-protein and incubated in the dark for 4 days at 37°C in a water bath shaker. Control LP were similarly treated utilizing PBS alone. In order to identify a possible interference of the reducing agent itself, control incubations were also carried out with LP and glucose, or LP and NaCNBH 3 alone. Control and glycated LP were then exhaustively dialysed against the PBS. Partially purified CETP (approximately 0.572 mg of protein/ml) was glycated in the presence of sterile glucose 20 mmol/l in buffer (15 mmol/l Na 2 CO 3 , 35 mmol/l NaHCO 3 , 3 mmol/l NaN 3 ), pH 7.4 and 200 mmol/l of NaCNBH 3 . Control incubations were carried out as described above.
Control and "in vitro" glycated LP utilized in the incubations were re-isolated by sequential ultracentrifugation within their original density ranges. Purified LP were combined to provide a total cholesterol mass ratio of 3/1 for LDL/HDL 2 or HDL 3 and 1/1 for VLDL/HDL 2 or HDL 3 roughly approximating their ratios in normal plasma. In addition, in experiments where lipoproteins were drawn from diabetic subjects and normal control subjects, the concentrations of triglycerides in the acceptor lipoproteins (LDL or VLDL) and of cholesteryl ester in HDL, which is the donor of 14 C-cholesteryl ester, were identical. The absence of thiobarbituric acid-reactive substances (TBARS) [42] demonstrated that the oxidation of the glycated LP did not occur. In addition, the sialic acid content of LPs from the diabetic subjects, and "in vitro" LP glycated was similar to that of control LP (data not shown).
Measurement of glycation. LP glycation both "in vitro" and "in vivo" was measured by the TNBS reaction [43] . Additionally the incorporation of [2] [3] H]-D-glucose (New England Nuclear) was utilized for the measurement of the extent of LP glycation "in vitro". After exhaustive dialysis the lipoprotein incorporation values of 3 H-glucose disclosed that both the protein and the lipid components were simultaneously glycated. The degree of protein glycation was measured after extracting the lipid components with a mixture of chloroform:methanol (2:1, v:v), overnight at 4°C, followed by exhaustive chloroform extraction. Extracted phospholipids were separated by TLC with chloroform: acetone: methanol: acetic acid: water (5:2:1:1:0.5; v:v:v:v:v). Phosphatidylethanolamine, lecithin, lysophosphatidylcholine, sphingomyelin and phosphatidylserine (Nu-Chek Prep. Incorporated, Elysian, Minn., USA) standards were utilized. Phospholipid bands were scraped into Acquasol (DuPont, Boston, Mass., USA) containing vials for radioactivity determination, whereas the protein-containing water phase was directly added to the radioactivity counting vials.
Electrophoresis. In order to qualitatively check LP alterations elicited by the glucose modification samples LP were submitted to electrophoresis on 1 % agarose gel [44] and stained with Oil red for apoB-containing LP and Sudan black for HDL subfractions.
Reconstitution of HDL. HDL from control plasma donors were separated by sequencial ultracentrifugation in the density range 1.085-1.21 g/ml and purified by discontinuous gradient density ultracentrifugation. In order to delipidate HDL, after dialysis against PBS, HDL (2 ml) was added to 40 ml of ethanol:ethyl-ether (3:2, v:v) containing 0.02 mmol/l of butylatedhydroxytoluene (BHT) and stored frozen for 3 h [45] . The solvent phase was aspirated after sample centrifugation for 15 min at 3000 rev/min at 4°C. The procedure was repeated with an additional overnight extraction with ethyl-ether. The lipid extracted phase was dried on a rotor-evaporator, re-diluited with ethyl-ether and transferred to vials containing 3 m Ci of 14 C-cholesteryl oleate. Both the lipid and the protein pellet were dried under N 2 and immediately utilized in the experiments described below.
Both components were glycated by exposure to concentrated glucose and NaCNBH 3 , as described above. Also, this procedure was carried out on sonication in the Branson Cell Disruptor model 450, with a 3/8 titanium tip (Branson Sonifier, Danbury, USA) during 2 min, at 40 W, on an ice bath.
HDL particles were reconstituted by sonication of the lipid component during 2 cycles of 2 min each at 40 W. The protein solution was then added to the lipid fraction and further sonified in 2-min bursts for 40 min with 2-min resting intervals to avoid temperature elevation. Reconstituted HDL (recHDL) was submitted to discontinuous gradient density ultracentrifugation at the 1.085-1.21 g/ml density range. In addition experiments with 3 H-glucose incorporation showed that the radioactivity was present solely in the LP fraction submitted to glycation.
Assay of cholesteryl ester transfer protein activity. The transfer of 14 C-cholesteryl ester from HDL to apoB-containing LP was carried out among several combinations of lipoproteins from normal control subjects and from diabetic subjects, as well as LP that were glycated "in vitro". Transfer rates were measured from 2 to 4 h incubation periods since previous studies have shown that radioactive transfer reflects cholesteryl ester mass transfer between LPs [46] . Incubations were done in the presence of CETP at 37°C and were properly corrected for blank values at 4°C. Plasma d > 1. A possible interference of glycation on LP precipitation with dextran sulphate/MgCl 2 was ruled out after measuring protein in the supernatant of the incubated control and glycated HDL or LDL that had previously been purified by ultracentrifugation.
In the assays utilizing partially purified CETP, the donor and acceptor control LP, 14 C-cholesteryl ester HDL 2 and LDL, respectively, were incubated either with control or with glycated CETP (28 m g).
Statistical analyses. Mann Whitney test was used to compare median values of percent transfer. Two-tailed tests of significance were utilized and a p-value of less than 0.05 was considered statistically significant.
Results

Measurement of glycation. Incorporation of 3
H-glucose into LP was time-dependent ( Fig. 1) and occurred simultaneously in the lipid and in the protein fractions, although clearly predominantly in the latter component (Fig. 2) . Furthermore, most of the lipid 3 H-glucose content was present in the phosphatidylethanolamine moiety (data not shown). The percent of the protein lysine residues that were derivatized "in vitro" was estimated by the TNBS reaction (Fig. 3) . It was also shown that the percent of lysine residues that had been modified in LP obtained from diabetic subjects was approximately 70, 19, 24 and 19 % for VLDL, LDL, HDL 2 and HDL 3 , respectively.
Electrophoresis. As compared to native LP, glycated LDL and VLDL moved faster on the agarose gel, apparently due to the glycation of the NH 3 groups, particularly of Lys and Arg [26, 30] . As for the HDL 2 and HDL 3 fractions, glucose incorporation had no influence on their migration pattern (Fig. 4) as previously shown by Fournier et al. [33] . In regard to apoB containing-LP or HDL migration rates were similar for LP from diabetic patients and from the control subjects.
Measurement of the Esterification Rate.
In the presence of plasma d > 1.21 g/ml as the source of LCAT a 50 % decrease of the esterification rate of cholesterol occurred in assays carried out with glycated HDL: esterification values were 76 % in HDL 2 control, 33 % in HDL 2 glycated, 82 % in HDL 3 control and 40 % in HDL 3 glycated.
Transfer of 14 
C-cholesteryl ester from HDL to LDL or VLDL.
The transfer of radioactive cholesteryl oleate from HDL to apoB-containing from normal donors and diabetic subjects was measured during 2 and 4 h incubation periods and represents the percent transfer properly corrected for microgram of protein of the acceptor LP (LDL or VLDL) ( Table 1) . Greater transfer values were found between LP of diabetic as compared to those of control subjects. This difference Figure 1 . Migration lanes indicated on the bottom of the figures: 1 = non-glycated control; 2 through 6 according to the glycation sequence at 2, 4, 24, 48 and 96 h of incubation, respectively. Gel migration rate along time on LP glycation was faster for VLDL and LDL, and not modified for HDL 2 and HDL 3 in transfer rates was brought about by donor as well as by acceptor LP. Plasma infranatant (d > 1.21 g/ml) utilized as the source of CETP did not influence the transfer rate when diabetic patients were compared to normal control subjects.
The percent transfer of radiolabelled cholesteryl ester from HDL subfractions to LDL during 4 h incubations is shown in Table 2 . Glycation of the donor and acceptor LP simultaneously, effectively increased the transfer rate when compared to the values observed between control lipoproteins. Also "in vitro" glycation of HDL alone appears to play the major role in enhancing the transfer rate. Furthermore, the extent of transfer was significantly greater from HDL 3 than from HDL 2 .
The percent transfer values of 14 C-cholesteryl ester from HDL 2 to LDL, shown as median (range) of the quintuplicate samples incubated, were: normal control subjects 27 % (25-30); HDL 2 pre-treated either with glucose 26 % (25-29), or with NaCNBH 3 17 % (14-27) alone, or after pre-treatment with glucose and NaCNBH 3 27 % (20-33). Therefore, the presence of NaCNBH 3 in the incubation medium and its resultant product -glycyllysine -does not explain the enhanced transfer rate elicited by LP glycation.
The influence of glycation time on the percent transfer of 14 C-cholesteryl ester from HDL to LDL was investigated by incubating HDL 3 with glucose and NaCNBH 3 for 2 to 96 h ( Table 3) . As compared to the control LP, glycation of HDL for under 48 h did not modify the rate of transfer. However, the 96 h glycation significantly increased the percent transferred.
Reconstituted HDL was utilized to assess the influence of the independent glycation of the lipid or of the protein moiety on the cholesteryl ester transfer process. Glycation of the protein component enhanced the rates of cholesteryl ester transfer to LDL or VLDL, whereas glucose incorporation in the lipid fraction of HDL played no role. Unexpectedly, when the two components of HDL (lipids and proteins) were simultaneously glycated the enhanced transfer rate ascribed to the protein fraction was cancelled (Table 4) .
CETP activity was markedly impaired by its "in vitro" glycation: when HDL 2 was incubated with LDL and highly purified CETP, the median (range) percent transfer values were 23 % (11-29) with control CETP, and 3.3 % (0-9) with glycated CETP. Diminished CETP activity was also observed in similar experiments (n = 4) when incubations of CETP were carried out only in the presence either of NaCNBH 3 or glucose: CETP control = 11 % (10-16); CETP plus glucose = 6 % (2-8); CETP plus NaC-NBH 3 = 0.6 % (0-2.2).
Discussion
Previous studies have indicated that the transfer of cholesteryl ester from HDL to lighter density LP is altered in the diabetic state [3] [4] [5] [6] [7] . Nonetheless, the primary cause of an increased transfer rate has recently been ascribed to an elevated plasma concentration of LP that are acceptors of cholesteryl ester [6, 24] . In this regard the plasma concentration of CETP is consistently within the normal range in diabetic patients [4, 24] . One study claims that micro and macroalbuminuria relates to CETP alteration in diabetes mellitus [23] ; however, the CETP mass was indirectly measured. Conceivably the presence of albuminuria and not diabetes itself might bring on a rise in plasma CETP concentration since the latter is known to occur in the nephrotic syndrome [47] .
The present study investigates the possibility that glycation of the plasma LP might explain the greater transfer of cholesteryl ester from HDL to the atherogenic LP, mediated by CETP, provided that the plasma levels of the latter are not raised by diabetes. This possibility is supported by the fact that glycation of plasma LP is elevated in diabetic subjects, which relates to several lipid and LP disturbances in this disease [1, 32, 48, 49] .
In our study the "in vitro" concentrations of triglycerides from the acceptor LP and of cholesteryl ester from the donor LP were identical in the samples of the diabetic subjects and of the normal control subjects. Furthermore, transfer rates were also corrected for the concentration of the apoB. Significantly greater transfer rates of cholesteryl ester from HDL to LDL or VLDL were observed in the LP of diabetic patients which could relate to the elevated level of glycated haemoglobin that reflects poor glycaemic control. Furthermore, this finding agrees with the greater transfer rate that takes place due to the LP glycation "in vitro". The phospholipid glycation, particularly of phosphatidylethanolamine, reported here, agrees with previous data by Cerami et al. [49] where this spontaneous biochemical reaction was associated with the genesis of the LP oxidation and, as indicated by others, to the clinical complications of diabetes [48] . However, in the present study, the absence of elevated TBARS in glycated LP indicates that oxidation is low, perhaps due to the presence of EDTA in the medium. Glycation of the lipid component alone in the reconstituted HDL did not influence the CETP activity. On the contrary, glycation of the protein fraction of the rec-HDL was responsible for the faster CETP-mediated transfer of cholesteryl ester to the apoB-containing LP.
Incubation of partially purified CETP with sodium cyanoborohydride and glucose markedly diminished the cholesteryl ester transfer rate. However, CETP activity was independently affected by incubation with glucose or with NaCNBH 3 alone. Treatment of HDL 2 with sodium cyanoborohydride alone did not influence the HDL cholesteryl ester transfer rate to LDL, and thus cannot explain the increased transfer rate elicited by glycation in the presence of cyanoborohydride.
Mechanisms whereby LP and CETP glycation interfere with lipid transfer between HDL and LDL were not considered in this study, but chemical analyses of the LP (data are not shown) did not disclose any difference between the glycated and normal LP in regard to their protein, triglycerides, unesterified and esterified cholesterol or phospholipid contents. Conceivably, LP particle modification by glucose enhances the affinity of CETP to the LP. Our results resemble a previous study where LP acetylation and succinylation stimulate the transfer of cholesteryl ester from HDL to LDL [50] .
It has been shown that CETP-LP interactions take place through hydrophobic and electrostatic affinity between CETP positive and LP negative surface sites [2, 12] . Glycation is known to mask positive Lys residues that alone could sharply impair the CETP affinity for the LP. Even the N-glycosylation that takes place during translation, when oligosacharides and sialic acid are added to the CETP asparagine, may influence the CETP role on the transfer of neutral lipids [12, 51] . However, our transfer studies utilizing diabetic plasma as the source of CETP indicate that glycation of the latter does not seem to occur in these patients.
Several papers suggest that the transfer rate of cholesteryl ester from HDL to apoB-containing LP is enhanced in IDDM and NIDDM [3] [4] [5] [6] [7] , and seemingly relates to the level of haemoglobin glycation [4, 6, 7, 23] . Nonetheless, because of the apparently contradictory effects of this modification on different LP classes it is uncertain whether LP glycation in the diabetic plasma bears a relationship to atherogenesis. For instance, glycation of LDL might be atherogenic to the extent that it slows down the LDL turnover [26, 32] , therefore raising the concentration of LDL in plasma. Glycation of HDL, on the other hand, markedly accelerates its turnover in plasma [31] , and thus its faster transfer rate of cholesteryl ester to LDL shown "in vitro" may not be relevant to the "in vivo" process of reverse cholesterol transport that takes place in the plasma compartment. Nonetheless, from the arterial wall view point, a greater cholesteryl ester content of the atherogenic LP made available to the macrophages consequently to the glycation should aggravate the development of atherosclerosis [34, 52] . In this regard, the first step of the reverse cholesterol transport, that is, the rate of cholesterol removal from the cell by HDL is impaired by the LP glycation [28, 33, 35] . Since CETP also participates in the uptake of cell cholesterol by HDL [53] , glycation of CETP might also influence the process of cell cholesterol removal. Thus, uncontrolled diabetes potentially favours the arterial wall cholesterol accumulation secondarily to the interplay of several steps along the reverse cholesterol transport pathway involving glycation of LCAT, CETP, HDL and LDL that impairs the removal of cell cholesterol and its esterification rate while simultaneously favouring the cholesterol enrichment of the atherogenic LP and its uptake by the macrophages. At present it is not known which step is preferentially modified by diabetes at the arterial intima site.
